tiprankstipranks
Trinity Biotech (TRIB)
:TRIB
Holding TRIB?
Track your performance easily

Trinity Biotech (TRIB) Stock Price & Analysis

294 Followers

TRIB Stock Chart & Stats


Financials

Annual

Ownership Overview

0.03%0.20%99.77%
Insiders
0.20% Other Institutional Investors
99.77% Public Companies and Individual Investors

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

TRIB FAQ

What was Trinity Biotech’s price range in the past 12 months?
Trinity Biotech lowest stock price was $0.75 and its highest was $3.55 in the past 12 months.
    What is Trinity Biotech’s market cap?
    Trinity Biotech’s market cap is $9.33M.
      When is Trinity Biotech’s upcoming earnings report date?
      Trinity Biotech’s upcoming earnings report date is Apr 02, 2025 which is in 73 days.
        How were Trinity Biotech’s earnings last quarter?
        Trinity Biotech released its earnings results on Nov 15, 2024. The company reported -$0.458 earnings per share for the quarter, beating the consensus estimate of -$0.54 by $0.082.
          Is Trinity Biotech overvalued?
          According to Wall Street analysts Trinity Biotech’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Trinity Biotech pay dividends?
            Trinity Biotech pays a Annually dividend of $1.095 which represents an annual dividend yield of N/A. See more information on Trinity Biotech dividends here
              What is Trinity Biotech’s EPS estimate?
              Trinity Biotech’s EPS estimate is -0.3.
                How many shares outstanding does Trinity Biotech have?
                Trinity Biotech has 18,053,679 shares outstanding.
                  What happened to Trinity Biotech’s price movement after its last earnings report?
                  Trinity Biotech reported an EPS of -$0.458 in its last earnings report, beating expectations of -$0.54. Following the earnings report the stock price went down -7.432%.
                    Which hedge fund is a major shareholder of Trinity Biotech?
                    Currently, no hedge funds are holding shares in TRIB
                    ---

                    Company Description

                    Trinity Biotech

                    Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.
                    ---

                    TRIB Earnings Call

                    Q3 2024
                    0:00 / 0:00
                    Earnings Call Sentiment|Neutral
                    The earnings call reflected a company in transition, with significant improvements in revenue growth and cost reduction measures. However, challenges remain, particularly in the hemoglobin segment and overall net loss, indicating a mixed outlook.Read More>
                    ---
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Accelerate Diagnostics
                    Quanterix
                    Haemonetics
                    Bio-Rad Laboratories
                    Hologic
                    Illumina
                    Popular Stocks
                    ---
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis